Cognizant has expanded its agreement with biopharmaceutical company Gilead Sciences to manage its global IT infrastructure, platforms and applications, and lead initiatives to accelerate its digital transformation. Cognizant had previously partnered with Gilead for over three years and the new agreement will see its services renewed and expanded over the next five years, with a total value of $800 million.